P I Industries Ltd
P I Industries Q2 Results 2026 (FY27) investor presentation: Revenue & Margins
Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.
Get P I Industries Ltd's next results in your feed
Guidance rank: #19 of 23 in Fertilizers & Agrochemicals
See the sector's top 10 — free with your mobile number.
Based on P I Industries Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q2 FY27 consolidated revenue: INR 17,018 Mn (down 9% YoY from INR 18,723 Mn in Q2 FY26). Q2 FY27 EBITDA: INR 2,362 million, down from INR 5,434 million in Q2 FY26 (−57% YoY).
From P I Industries Ltd's Q2 FY27 earnings-call transcript · updated 4 Nov 2026.
How did P I Industries' revenue grow in the September 2026 quarter?
- Q2 FY27 consolidated revenue: INR 17,018 Mn (down 9% YoY from INR 18,723 Mn in Q2 FY26)
- Q2 FY27 Domestic revenue grew 19% YoY
- Agchem exports declined about 18% YoY due to soft demand and pricing pressure
- Biologicals revenue grew aggressively by 45%+ domestically and 250% globally
- Health Sciences revenue grew 20% in Q2 FY27
- H1 FY27 consolidated revenue: INR 34,041 Mn (4% decline YoY from INR 37,728 Mn in H1 FY26)
- Q2 FY27 Gross Margin declined to 49% from 57% YoY; EBITDA margin dropped to 14% from 29%
- Outlook: Expect acceleration of growth with 5+ new products to be commercialized in FY27
2 more points from P I Industries Ltd's call on revenue
Create a free account to keep reading this call
What happened to P I Industries' margins in Q2 FY27?
See what P I Industries Ltd said on profitability & margins — free account, 30 seconds.
What capex is P I Industries planning?
- Total capex for H1FY27 was INR 5,674 million, allocated to efficiencies, capacities, new initiatives, and R&D (Page 7).
- Capital expenditure underway as per plan with 3 Multi-Product Pipelines (MPPs) under construction (Page 20).
- Building dedicated development and manufacturing capacities; infrastructure in Lodi, Italy reaching mature phase (Page 15).
- Specialty/electronic chemicals segment: Dedicated Electronic Chemicals (EC) Kilo Lab commercialization targeted by Q3 FY27 (Page 13).
2 more points from P I Industries Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Fertilizers & Agrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Is P I Industries raising money or cutting debt?
See what P I Industries Ltd said on fundraising & capital structure — free account, 30 seconds.
How big is P I Industries' order book?
See what P I Industries Ltd said on order book & pipeline — free account, 30 seconds.
P I Industries Ltd — Quarterly revenue & net profit
Q2 FY27 figures are not in this chart yet. Latest shown: Jun 2026 (Q1 FY27). The Q2 FY27 numbers from the filing are in the analysis on this page.
Reported quarterly figures (₹ Cr). Latest (Q1 FY27): revenue ₹1.7K Cr, net profit ₹244 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What P I Industries Ltd's management said in earlier quarters
- Q1 FY27 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q3 FY25 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q1 FY26 earnings call →
- Q4 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
Others in Fertilizers & Agrochemicals this season
- Dharmaj Crop (Q2 FY27)
Q2 FY27 Revenue from Operations: ₹332.6 Crore, a 4% year-on-year (YOY) decline from ₹347.3 Crore in Q2 FY26 (Page 7, Page 5). Key investor presentation takeaway
- Advance Agrolife (Q2 FY27)
Q2 FY27 Revenue from Operations: ₹2,871.5 million, up 35% YoY (Page 26) . Key investor presentation takeaways from Advance Agrolife Ltd's Q2 FY27 investor prese
- Meghmani Organics (Q2 FY27)
Q2 FY27 Revenue from Operations (Consolidated): ₹666.9 crore, up 16% YoY (Q2 FY26: ₹577.3 crore). Key investor presentation takeaways from Meghmani Organics Ltd
- India Pesticides (Q2 FY27)
Q2 FY2027 Revenue from Operations: ₹231 crore, down 21.6% YoY (Page 9, 5) . Key investor presentation takeaways from India Pesticides Ltd's Q2 FY27 investor pre
Potential multibaggers · Q2 FY27
Potential multibaggers in Fertilizers & Agrochemicals
on management's own guidance
- Dharmaj CropGood growth2
- Anya Polytech &Good growth1
- M B Agro Prod.Good growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
P I Industries Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were P I Industries Ltd Q2 FY27 results?
Q2 FY27 consolidated revenue: INR 17,018 Mn (down 9% YoY from INR 18,723 Mn in Q2 FY26). Q2 FY27 EBITDA: INR 2,362 million, down from INR 5,434 million in Q2 FY26 (−57% YoY).
What is P I Industries Ltd share price analysis?
P I Industries Ltd currently shows a neutral. The stock trades at a P/E of 30.7 with a market cap of ₹33,181 Cr. Investors should review the full earnings analysis for detailed insights.
Is P I Industries Ltd planning capital expenditure?
Total capex for H1FY27 was INR 5,674 million, allocated to efficiencies, capacities, new initiatives, and R&D (Page 7).
Keep P I Industries Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
